Zareen Farukhi1, Samia Mora. 1. Division of Preventive Medicine, Division of Cardiovascular Medicine, Department of Medicine, Center for Lipid Metabolomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Nonfasting lipid testing has been introduced into several guidelines over the past decade or so however, the uptake into clinical practice has not been universal. This review highlights some of the prevalent reasons for provider reluctance to use nonfasting testing and the evidence to support nonfasting testing for routine screening in most patients. RECENT FINDINGS: Several studies have found nonfasting lipids to be as, or more, strongly associated with cardiovascular disease (CVD) risk prediction. In particular, nonfasting tests improve system efficiency, are safe for patients with diabetes, the elderly, children, and in the vast majority of patients, do not need to be followed up with fasting studies due to severe hypertriglyceridemia. SUMMARY: Nonfasting lipids are a convenient first test for screening that offers equivalent, if not improved CVD risk prediction. Common misconceptions about nonfasting tests are not supported by the evidence.
PURPOSE OF REVIEW: Nonfasting lipid testing has been introduced into several guidelines over the past decade or so however, the uptake into clinical practice has not been universal. This review highlights some of the prevalent reasons for provider reluctance to use nonfasting testing and the evidence to support nonfasting testing for routine screening in most patients. RECENT FINDINGS: Several studies have found nonfasting lipids to be as, or more, strongly associated with cardiovascular disease (CVD) risk prediction. In particular, nonfasting tests improve system efficiency, are safe for patients with diabetes, the elderly, children, and in the vast majority of patients, do not need to be followed up with fasting studies due to severe hypertriglyceridemia. SUMMARY: Nonfasting lipids are a convenient first test for screening that offers equivalent, if not improved CVD risk prediction. Common misconceptions about nonfasting tests are not supported by the evidence.
Authors: Vasanth Sathiyakumar; Jihwan Park; Asieh Golozar; Mariana Lazo; Renato Quispe; Eliseo Guallar; Roger S Blumenthal; Steven R Jones; Seth S Martin Journal: Circulation Date: 2017-10-16 Impact factor: 29.690
Authors: Sarah D de Ferranti; Julia Steinberger; Rebecca Ameduri; Annette Baker; Holly Gooding; Aaron S Kelly; Michele Mietus-Snyder; Mark M Mitsnefes; Amy L Peterson; Julie St-Pierre; Elaine M Urbina; Justin P Zachariah; Ali N Zaidi Journal: Circulation Date: 2019-03-26 Impact factor: 29.690
Authors: Todd J Anderson; Jean Grégoire; Glen J Pearson; Arden R Barry; Patrick Couture; Martin Dawes; Gordon A Francis; Jacques Genest; Steven Grover; Milan Gupta; Robert A Hegele; David C Lau; Lawrence A Leiter; Eva Lonn; G B John Mancini; Ruth McPherson; Daniel Ngui; Paul Poirier; John L Sievenpiper; James A Stone; George Thanassoulis; Richard Ward Journal: Can J Cardiol Date: 2016-07-25 Impact factor: 5.223
Authors: Paul S Jellinger; Yehuda Handelsman; Paul D Rosenblit; Zachary T Bloomgarden; Vivian A Fonseca; Alan J Garber; George Grunberger; Chris K Guerin; David S H Bell; Jeffrey I Mechanick; Rachel Pessah-Pollack; Kathleen Wyne; Donald Smith; Eliot A Brinton; Sergio Fazio; Michael Davidson Journal: Endocr Pract Date: 2017-04 Impact factor: 3.443
Authors: Zareen M Farukhi; Olga V Demler; Michael P Caulfield; Krishnaji Kulkarni; Jay Wohlgemuth; Michael Cobble; Heike Luttmann-Gibson; Chunying Li; John R Nelson; Nancy R Cook; Julie E Buring; Ronald M Krauss; JoAnn E Manson; Samia Mora Journal: J Clin Lipidol Date: 2020-02-21 Impact factor: 4.766
Authors: Maureen Sampson; Clarence Ling; Qian Sun; Roa Harb; Mohmed Ashmaig; Russell Warnick; Amar Sethi; James K Fleming; James D Otvos; Jeff W Meeusen; Sarah R Delaney; Allan S Jaffe; Robert Shamburek; Marcelo Amar; Alan T Remaley Journal: JAMA Cardiol Date: 2020-05-01 Impact factor: 14.676
Authors: Brian A Ference; Henry N Ginsberg; Ian Graham; Kausik K Ray; Chris J Packard; Eric Bruckert; Robert A Hegele; Ronald M Krauss; Frederick J Raal; Heribert Schunkert; Gerald F Watts; Jan Borén; Sergio Fazio; Jay D Horton; Luis Masana; Stephen J Nicholls; Børge G Nordestgaard; Bart van de Sluis; Marja-Riitta Taskinen; Lale Tokgözoglu; Ulf Landmesser; Ulrich Laufs; Olov Wiklund; Jane K Stock; M John Chapman; Alberico L Catapano Journal: Eur Heart J Date: 2017-08-21 Impact factor: 29.983
Authors: Amal Rammah; Kristina W Whitworth; Christopher I Amos; Marisa Estarlich; Mònica Guxens; Jesús Ibarluzea; Carmen Iñiguez; Mikel Subiza-Pérez; Martine Vrijheid; Elaine Symanski Journal: Int J Environ Res Public Health Date: 2021-09-04 Impact factor: 3.390